Altimmune Inc (ALT)
7.70
+0.54
(+7.54%)
USD |
NASDAQ |
May 09, 16:00
7.58
-0.12
(-1.56%)
After-Hours: 19:56
Altimmune Price: 7.70 for May 9, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 08, 2024 | 7.04 | 7.55 | 6.81 | 7.16 | 4.409M |
May 07, 2024 | 7.40 | 7.40 | 7.045 | 7.27 | 1.705M |
May 06, 2024 | 7.38 | 7.51 | 7.25 | 7.36 | 1.595M |
May 03, 2024 | 7.41 | 7.63 | 7.19 | 7.30 | 2.019M |
May 02, 2024 | 7.18 | 7.35 | 6.81 | 7.19 | 2.681M |
May 01, 2024 | 6.64 | 7.39 | 6.55 | 7.07 | 4.119M |
Apr 30, 2024 | 6.35 | 6.73 | 6.31 | 6.55 | 3.215M |
Apr 29, 2024 | 6.86 | 6.89 | 6.282 | 6.395 | 4.928M |
Apr 26, 2024 | 7.18 | 7.42 | 6.90 | 7.26 | 2.251M |
Apr 25, 2024 | 6.88 | 7.25 | 6.78 | 7.20 | 2.316M |
Apr 24, 2024 | 7.55 | 7.75 | 6.98 | 7.08 | 2.205M |
Apr 23, 2024 | 7.47 | 8.23 | 7.47 | 7.57 | 3.132M |
Apr 22, 2024 | 7.03 | 7.55 | 6.85 | 7.47 | 2.370M |
Apr 19, 2024 | 6.85 | 7.01 | 6.64 | 6.91 | 3.591M |
Apr 18, 2024 | 6.97 | 7.26 | 6.85 | 6.89 | 3.216M |
Apr 17, 2024 | 7.65 | 7.65 | 7.01 | 7.04 | 3.641M |
Apr 16, 2024 | 7.42 | 7.65 | 7.23 | 7.52 | 2.724M |
Apr 15, 2024 | 7.95 | 7.98 | 7.32 | 7.55 | 3.527M |
Apr 12, 2024 | 8.33 | 8.33 | 7.75 | 7.99 | 3.046M |
Apr 11, 2024 | 8.07 | 8.54 | 7.958 | 8.40 | 2.832M |
Apr 10, 2024 | 8.05 | 8.35 | 7.96 | 8.01 | 2.894M |
Apr 09, 2024 | 8.60 | 8.71 | 8.11 | 8.40 | 2.882M |
Apr 08, 2024 | 9.09 | 9.15 | 8.55 | 8.61 | 2.340M |
Apr 05, 2024 | 8.83 | 9.17 | 8.63 | 9.09 | 2.938M |
Apr 04, 2024 | 9.35 | 9.52 | 8.86 | 8.90 | 3.050M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.53
Minimum
Nov 19 2019
33.26
Maximum
Jul 20 2020
8.708
Average
8.855
Median
Price Benchmarks
Eli Lilly and Co | 771.36 |
Amgen Inc | 313.12 |
Pfizer Inc | 28.20 |
Viking Therapeutics Inc | 80.18 |
Precision BioSciences Inc | 10.76 |
Price Related Metrics
PS Ratio | 962.28 |
Price to Book Value | 2.812 |
Earnings Yield | -21.69% |
Market Cap | 545.89M |